Cited by 60

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Understanding longevity in Hong Kong: a comparative study with long-living, high-income countries

Ni, Michael Y, Canudas-Romo, Vladimir, Shi, Jian, Flores, Francis P, Chow, Mathew S C, Yao, Xiaoxin I, Ho, Sai Yin, Lam, Tai Hing, Schooling, C Mary, Lopez, Alan D, Ezzati, Majid, Leung, Gabriel M·2021·The Lancet Public Health

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-2667(21)00208-5

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Trends in life expectancy at birth in Hong Kong (A) and contributions to life expectancy gains by age, sex, and underlying cause of death (B) (A) Life expectancy at birth in Hong Kong: 1960-2020. World rankings in life expectancy were obtained from the World Bank. Joinpoint analysis was used to identify when life expectancy gains in Hong Kong took place. Inflections in the life expectancy at birth identified by the jointpoint regression are indicated by the dotted lines and the year. The solid blue and red lines indicate the trends in life expectancy at birth for men and women and were predicted using Joinpoint analysis. (B) Contributions to life expectancy gains by age, sex, and underlying cause of death: 1979-2019.
Figure 1 Trends in life expectancy at birth in Hong Kong (A) and contributions to life expectancy gains by age, sex, and underlying cause of death (B) (A) Life expectancy at birth in Hong Kong: 1960-2020. World rankings in life expectancy were obtained from the World Bank. Joinpoint analysis was used to identify when life expectancy gains in Hong Kong took place. Inflections in the life expectancy at birth identified by the jointpoint regression are indicated by the dotted lines and the year. The solid blue and red lines indicate the trends in life expectancy at birth for men and women and were predicted using Joinpoint analysis. (B) Contributions to life expectancy gains by age, sex, and underlying cause of death: 1979-2019.CC-BY-NC-ND · From the PDF
Figure 2 Contributions to the difference in life expectancy between Hong Kong and 18 OECD high-income countries in 2016
Figure 2 Contributions to the difference in life expectancy between Hong Kong and 18 OECD high-income countries in 2016CC-BY-NC-ND · From the PDF
Figure 3 Lexis surface of cohort survival comparisons between Hong Kong and 18 OECD high-income countries and cause of death contribution to their differences in cohort survival (A) Lexis surface of cohort survival comparisons between Hong Kong and high-income countries. Diagonally, the figures show the mortality pattern of each cohort from birth (or the age when data are first available) to older age from 1979 to 2016. The black diagonal lines indicate the mortality history of cohorts born in a specific year. Blue shades indicate Hong Kong's cohort survival advantage and red and yellow shades indicates disadvantage. (B) Lexis surface of the cause of death contribution to the difference in cohort survival between Hong Kong and high-income countries for selected diseases. Differences in the cohort survival by cause of death are calculated as TCAL (Hong Kong) -TCAL (high-income country). (C) Cause of death contribution to differences in cohort survival between Hong Kong and high-income countries. Positive values indicate that Hong Kong has a survival advantage. The size of the bubbles corresponds to the 95% CIs, which are calculated by bootstrapping. If the bubble does not overlap the dotted horizontal line then this indicates that the TCAL for the country is significantly different from Hong Kong. TCAL=truncated cross-sectional average of life.
Figure 3 Lexis surface of cohort survival comparisons between Hong Kong and 18 OECD high-income countries and cause of death contribution to their differences in cohort survival (A) Lexis surface of cohort survival comparisons between Hong Kong and high-income countries. Diagonally, the figures show the mortality pattern of each cohort from birth (or the age when data are first available) to older age from 1979 to 2016. The black diagonal lines indicate the mortality history of cohorts born in a specific year. Blue shades indicate Hong Kong's cohort survival advantage and red and yellow shades indicates disadvantage. (B) Lexis surface of the cause of death contribution to the difference in cohort survival between Hong Kong and high-income countries for selected diseases. Differences in the cohort survival by cause of death are calculated as TCAL (Hong Kong) -TCAL (high-income country). (C) Cause of death contribution to differences in cohort survival between Hong Kong and high-income countries. Positive values indicate that Hong Kong has a survival advantage. The size of the bubbles corresponds to the 95% CIs, which are calculated by bootstrapping. If the bubble does not overlap the dotted horizontal line then this indicates that the TCAL for the country is significantly different from Hong Kong. TCAL=truncated cross-sectional average of life.CC-BY-NC-ND · From the PDF
Figure 4 Smoking-attributable mortality
Figure 4 Smoking-attributable mortalityCC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 41

  1. Kontis, 2020, Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries, Nat Med, 26, 1919, 10.1038/s41591-020-1112-0 · DOI · Paper page
  2. Andrasfay, 2021, Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations, Proc Natl Acad Sci USA, 118, 10.1073/pnas.2014746118 · DOI
  3. Iacobucci, 2017, Increase in life expectancy in England has halted, new figures show, BMJ, 358
  4. Zhou, 2016, Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013, Lancet, 387, 251, 10.1016/S0140-6736(15)00551-6 · DOI
  5. Leung, 2017, Cohort profile: FAMILY cohort, Int J Epidemiol, 46, e1, 10.1093/ije/dyu257 · DOI
  6. Chung, 2010, How does socioeconomic development affect risk of mortality? An age-period-cohort analysis from a recently transitioned population in China, Am J Epidemiol, 171, 345, 10.1093/aje/kwp378 · DOI
  7. Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z · DOI
  8. Arriaga, 1984, Measuring and explaining the change in life expectancies, Demography, 21, 83, 10.2307/2061029 · DOI · Paper page
  9. Bennett, 2018, Contributions of diseases and injuries to widening life expectancy inequalities in England from 2001 to 2016: a population-based analysis of vital registration data, Lancet Public Health, 3, e586, 10.1016/S2468-2667(18)30214-7 · DOI
  10. Canudas-Romo, 2020, Reflection on modern methods: cause of death decomposition of cohort survival comparisons, Int J Epidemiol, 49, 1712, 10.1093/ije/dyz276 · DOI
  11. Canudas-Romo, 2015, Truncated cross-sectional average length of life: a measure for comparing the mortality history of cohorts, Popul Stud, 69, 147, 10.1080/00324728.2015.1019955 · DOI
  12. Peto, 1992, Mortality from tobacco in developed countries: indirect estimation from national vital statistics, Lancet, 339, 1268, 10.1016/0140-6736(92)91600-D · DOI · Paper page
  13. Ezzati, 2003, Estimates of global mortality attributable to smoking in 2000, Lancet, 362, 847, 10.1016/S0140-6736(03)14338-3 · DOI · Paper page
  14. Liu, 1998, Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths, BMJ, 317, 1411, 10.1136/bmj.317.7170.1411 · DOI
  15. Lam, 2001, Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998, BMJ, 323, 361, 10.1136/bmj.323.7309.361 · DOI
  16. Burns, 1987, Immigration from China and the future of Hong Kong, Asian Surv, 27, 661, 10.2307/2644542 · DOI
  17. Oeppen, 2002, Demography. Broken limits to life expectancy, Science, 296, 1029, 10.1126/science.1069675 · DOI · Paper page
  18. Yao, 2019, Change in moderate alcohol consumption and quality of life: evidence from 2 population-based cohorts, CMAJ, 191, E753, 10.1503/cmaj.181583 · DOI
  19. Cao, 2015, Light to moderate intake of alcohol, drinking patterns, and risk of cancer: results from two prospective US cohort studies, BMJ, 351
  20. Liu, 2019, A territorywide prevalence study on blood-borne and enteric viral hepatitis in Hong Kong, J Infect Dis, 219, 1924, 10.1093/infdis/jiz038 · DOI
  21. Tian, 2019, Ambient particulate matter pollution and adult hospital admissions for pneumonia in urban China: a national time series analysis for 2014 through 2017, PLoS Med, 16, 10.1371/journal.pmed.1003010 · DOI
  22. Powles, 2010, National cardiovascular prevention should be based on absolute disease risks, not levels of risk factors, Eur J Public Health, 20, 103, 10.1093/eurpub/ckp067 · DOI
  23. Lopez, 2019, Is the long-term decline in cardiovascular-disease mortality in high-income countries over? Evidence from national vital statistics, Int J Epidemiol, 48, 1815, 10.1093/ije/dyz143 · DOI
  24. Adair, 2020, The role of overweight and obesity in adverse cardiovascular disease mortality trends: an analysis of multiple cause of death data from Australia and the USA, BMC Med, 18, 199, 10.1186/s12916-020-01666-y · DOI
  25. Carter, 2015, Smoking and mortality—beyond established causes, N Engl J Med, 372, 631, 10.1056/NEJMsa1407211 · DOI · Paper page
  26. Hyland, 2012, Smoke-free air policies: past, present and future, Tob Control, 21, 154, 10.1136/tobaccocontrol-2011-050389 · DOI
  27. Ma, 2021, Prevalence and trends in tobacco use among adolescents aged 13–15 years in 143 countries, 1999–2018: findings from the Global Youth Tobacco Surveys, Lancet Child Adolesc Health, 5, 245, 10.1016/S2352-4642(20)30390-4 · DOI
  28. Kendrick, 2021, Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019, Lancet Public Health, 6, e482, 10.1016/S2468-2667(21)00065-7 · DOI
  29. Khan, 2019, Effects of nutritional supplements and dietary interventions on cardiovascular outcomes: an umbrella review and evidence map, Ann Intern Med, 171, 190, 10.7326/M19-0341 · DOI · Paper page
  30. Mackay, 1986, Effects of strong government measures against tobacco in Hong Kong, Br Med J (Clin Res Ed), 292, 1435, 10.1136/bmj.292.6533.1435 · DOI
  31. Zhao, 2017, The incomparability of cause of death statistics under “one country, two systems”: Shanghai versus Hong Kong, Popul Health Metr, 15, 37, 10.1186/s12963-017-0155-z · DOI
  32. Thun, 2000, Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom, JAMA, 284, 706, 10.1001/jama.284.6.706 · DOI
  33. Boffetta, 2014, The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) project—design, population and data harmonization of a large-scale, international study, Eur J Epidemiol, 29, 929, 10.1007/s10654-014-9977-1 · DOI
  34. Ni, 2020, The epidemiology of population mental wellbeing in China, Lancet Public Health, 5, e631, 10.1016/S2468-2667(20)30265-6 · DOI
  35. Razum, 2006, Commentary: of salmon and time travellers—musing on the mystery of migrant mortality, Int J Epidemiol, 35, 919, 10.1093/ije/dyl143 · DOI
  36. Hastings, 2016, Mortality outcomes for Chinese and Japanese immigrants in the USA and countries of origin (Hong Kong, Japan): a comparative analysis using national mortality records from 2003 to 2011, BMJ Open, 6, 10.1136/bmjopen-2016-012201 · DOI
  37. Shen, 2013, Alcohol use and death from respiratory disease in a prospective Chinese elderly cohort study in Hong Kong, Prev Med, 57, 819, 10.1016/j.ypmed.2013.09.011 · DOI
  38. Oishi, 2014, Residents of poor nations have a greater sense of meaning in life than residents of wealthy nations, Psychol Sci, 25, 422, 10.1177/0956797613507286 · DOI · Paper page
  39. Ni, 2017, Longitudinal patterns and predictors of depression trajectories related to the 2014 Occupy Central/Umbrella Movement in Hong Kong, Am J Public Health, 107, 593, 10.2105/AJPH.2016.303651 · DOI
  40. Ni, 2020, Depression and post-traumatic stress during major social unrest in Hong Kong: a 10-year prospective cohort study, Lancet, 395, 273, 10.1016/S0140-6736(19)33160-5 · DOI · Paper page
  41. Ni, 2020, Determinants of physical, mental and social well-being: a longitudinal environment-wide association study, Int J Epidemiol, 49, 380, 10.1093/ije/dyz238 · DOI

Cited by

Sorted by citations

See all 60

Metadata

Authors
Ni, M. Y., Canudas-Romo, V., Shi, J., Flores, F. P., Chow, M. S. C., Yao, X. I., Ho, S. Y., Lam, T. H., Schooling, C. M., Lopez, A. D., Ezzati, M., & Leung, G. M.
Venue
The Lancet Public Health
Publisher
Elsevier BV
Published
2021-12
Volume
6
Issue
12
Pages
e919-e931
ISSN
2468-2667
Cited by
60
References
4
Language
en
Funders
University Grants Committee Research Grants Council

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review